Aims: In this study, we examined the expression of lncRNA ENST00000413528 in glioma and determined its role in glioma development.
| INTRODUC TI ON
Glioma is the most common primary brain tumor and often leads to fatal patient outcomes due to its highly invasive growth pattern and frequent resistance to therapies. 1, 2 In recent years, researchers have increasingly focused on the molecular regulatory networks involved in the development of gliomas and on possible new therapeutic targets. The discovery of mutations in specific genes, such as isocitrate dehydrogenase(IDH) gene mutations, 3 BRAF mutations, 4, 5 and histone mutations, 6 has changed our understanding of the pathogenesis of many types of gliomas and subsequently driven the biomarker-related classification of gliomas. 7 Notably, the current role of this classification system is not just as a supplement to diagnosis; instead, it goes beyond histological diagnosis.
Human genome sequence data show that most of the transcripts are noncoding ribonucleic acids (RNAs) and that only 2%
of the transcripts can encode proteins. 8 Extensive research has been conducted on microRNAs (miRNAs), confirming their role in the regulation of genes and in the function of cell biology in many cancers. 9 Recent studies have also shown that long noncoding RNAs (lncRNAs) play an important role in normal development and numerous diseases, including many kinds of cancers. 10, 11 Investigations have also been conducted on lncRNAs and their relevant pathways in glioma. P73 antisense RNA 1T (TP73-AS1) was upregulated in brain glioma tissues and cell lines and was associated with a poorer prognosis in patients with glioma. Additionally, they determined that TP73-AS1 may also act as a competing endogenous RNA (ceRNA) to promote HMGB1 expression by sponging miR-142 to promote the brain glioma growth and invasion.
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CeRNA is a known mechanism of lncRNA; in this mechanism, lncRNA competes for posttranscriptional control by sponging certain relevant miRNAs. 20 Previous surveys have confirmed some lncRNA-miRNA interaction pathways, 21, 22 which provide some theoretical basis for our current research.
Polo-like kinase 1 (PLK1) is a serine/threonine protein kinase that is known to be a key regulator of mitosis, with critical roles in cell cycle-associated processes. 25, 26 PLK1 is involved in the regulation of the cell cycle and the growth of various tumors, including breast cancer, renal cell cancer, and prostate cancer. 18, 27, 28 Two studies found some lncRNAs, such as Hox transcript antisense RNA (HOTAIR) and lnc-RI, exerted their regulatory effects through PLK1 31, 32 ; however, such lncRNA-PLK1 associated approach has not yet been observed in glioma cells.
In this study, we performed a lncRNA microarray in glioma tissues and found lncRNA ENST00000413528 was overexpressed.
After the qRT-PCR verification in glioma tissues and biological informational analysis, we found a possible ceRNA pathway of lncRNA ENST00000413528, which shared a complementary area with miR-593-5p, and associated with the target gene PLK1. We, thus, hypothesized that lncRNA ENST00000413528 may sponge miR-593-5p to regulate PLK1 to exert its effects on glioma cells and designed a series of experiments to verify our hypothesis.
| MATERIAL S AND ME THODS

| Ethics statement
The human studies included in this research were conformed to Declaration of Helsinki; both the human and animal studies were approved by the medical research ethics committee of the First Affiliated
Hospital of Zhengzhou University in Zhengzhou, China. All patients with glioma signed an informed consent prior to participation.
| Cells and tissues
The glioma cell lines U251, SNB19, U373, SHG44, and LN229 and normal human astrocytes (NHAs) were obtained from the American 
| LncRNA microarray of glioma tissues
| Cell transfection
| Cell colony formation assay
Cells with different treatments were seeded in the 3. Beijing, China). The number of colonies stained in the dish for analysis was then counted, and the experiment was repeated three times.
| Cell apoptosis assays
The number of apoptotic cells of each group was detected via the 
| Cell cycle detection
Cell cycle status of each group was detected by flow cytometry using a cell cycle detection kit (KenGen BioTECH, Jiangsu, China).
Cells (1 × 10 6 ) were dissociated with 0.25% trypsin without EDTA, washed twice with PBS, and fixed with 500 μL of 70% precooled ethanol for 2 hours. After fixation, the cells were washed with PBS once; 500 μL of the working solution (RNaseA: PI = 1:9) was then added to resuspend cells. After incubating cells in the dark for 30 to 60 minutes at room temperature, the red fluorescent signal at the excitation wavelength of 488 nm was detected. The analysis was performed and figures were created using Modfit software.
| Dual luciferase reporter assay
In order to verify the interaction between LncRNA 
| RNA immunoprecipitation assay
RNA immunoprecipitation (RIP) assay was performed using the 
| Statistical analysis
All cell experiments were repeated three times. SPSS 21 software (IBM Corp., Armonk, NY, USA) was used to perform the data analysis. Data were expressed in the format of the mean ± standard deviation (SD). A Student's t test, one-way analysis of variance, Pearson's
analysis was carried out to analyze the data. P < 0.05 was considered statistically significant.
| RE SULTS
| Detection and verification of lncRNA microarray in glioma tissues
The microarray of three human brain glioma tissues and the paired PTBE tissues showed 22 differential expressed lncRNAs, including 13 downregulated and nine upregulated ones ( Figure 1A , Table 1 ).
LncRNA ENST00000413528 was found to demonstrate a 3.58-fold change upregulation in the glioma specimens. To verify the microarray results, we performed the qRT-PCR of two upregulated and two downregulated lncRNAs in 16 paired human glioma tissues and their corresponding PTBE tissues ( Figure 1B ,C,D,E). Our results showed that the relative expression of ENST00000413528 or lnc-NUDT4-4:1 was higher in tumor tissues than that in PTBE tissues (P < 0.05), while NONHSAT207178 and NONHSAT174301 were downregulated in tumor tissues (P < 0.05), all of which were consistent with the microarray results. Thus, we confirmed that the data of the microarray were statistically credible. In addition, the morphological changes in glioma tissues were displayed by H&E staining in Figure 1G . PLK1, the targeted gene in our hypothesis, was also detected by IHC. PLK-1 protein could be mainly cytoplasmic stained in glioma tissues while hardly stained in PTBE tissues. The PLK1 expression showed a significantly and gradually increased tendency from PTBE, low-grade glioma to high-grade glioma tissues. We then detected the relative expression level of ENST00000413528 in different glioma cell lines for further study ( Figure 1F ). Expression of ENST00000413528 was significantly increased in glioma cell lines, especially in LN229 and U251 cells, when compared with NHA cells (P < 0.05). Therefore, we selected LN229 and U251 cells to carry out the next experiments. Figure 2I ; P < 0.05). Furthermore, we also assessed the cell cycle status in the two groups using flow cytometry and found that cells infected with si-Lnc had increased cell numbers in the G0/G1
phases, but reduced numbers in the S phase ( Figure 2H ; P < 0.05),
suggesting that si-Lnc-related cell cycle arrest occurred in the G0/ G1 checkpoints for LN229 and U251 cells. Glioma nude mice models constructed by si-Lnc or si-NC U251 cells were performed to evaluate the effects of ENST00000413528 on glioma cell growth in vivo. Results showed that the tumor volume and tumor weight of mice in the si-Lnc group were both significantly decreased when compared with these factors in the si-NC group ( Figure 2J ; P < 0.05).
Therefore, our results suggest that the downregulation of lncRNA ENST00000413528 may impair glioma cell growth, promote cell apoptosis in LN229 and U251 cells, and the proliferation inhibitory effect was also demonstrated in our xenograft mouse model constructed using U251 cells.
| LncRNA ENST00000413528 regulated miR-593-5p by direct targeting
Bioinformatics analysis demonstrated a complementary pairing area between the sequences of ENST00000413528 and miR-593-5p showed that the downregulation of lncRNA ENST00000413528 significantly increased miR-593 expression in both U251 and LN299 cells when compared with NC cells ( Figure 3C ; P < 0.05).
Similarly, the upregulation of miR-593 could also lead to a decrease of ENST00000413528 expression ( Figure 3D ; P < 0.05). We performed RIP assay to clarify whether ENST00000413528 and Correlation analysis between the relative expression of miR-593 and ENST00000413528 in glioma tissues demonstrated a negative correlation with R 2 at 0.4147 ( Figure 3G ; P < 0.05). Overall, the results of the dual luciferase reporter assay, RIP assay, and correlation analysis suggested that LncRNA ENST00000413528 directly targeted miR-593-5p.
| PLK1 was a target gene of miR-593-5p
MiRNAs regulate gene expression by binding to the three prime untranslated regions (UTRs) of their target genes. We performed the bioinformatics analysis and found a complementary pairing area between the sequences of miR-593-5p and PLK1 ( Figure 4A ). To verify whether PLK1 was a target gene of miR-593-5p, we performed the dual luciferase reporter assay. Recombinant plasmids pmirGLO-Wt-PLK1 3′UTR and pmirGLO-Mt-PLK1 3′UTR were cotransfected with miR-NC or miR-593 mimics into U251 and LN299 cells ( Figure 4C ).
Our results showed that the luciferase activity of the Wt-PLK1 luciferase reporter vector was notably suppressed in response to the miR-593 mimics' transfection when compared with the NC group (P < 0.05), indicating a direct combination between miR-593 and PLK1 3′UTR. Subsequently, the expression of the PLK1 protein in cells transfected with miR-593, NC control, or blank control was detected by western blotting ( Figure 4B ). The upregulation of miR-593 significantly decreased the PLK1 protein expression (P < 0.05).
Moreover, in glioma tissues, the relative expression of PLK1 protein was negatively correlated with miR-593 (R 2 = 0.5228, P < 0.05). or upregulating miR-593 ( Figure 5B ; P < 0.05). We also found that the cell cycle status was altered by transfecting with si-Lnc or miR-593 mimics versus that found in the NC groups, with an inhibition occurring in the S phase and a relative percent increase happening in the G0/G1 phase; furthermore, there was no significant difference in the effects of the ENST00000413528 knockdown and miR-593 overexpression on cell cycle regulation in U251 and LN229 cells ( Figure 5C ; P < 0.05). For antiapoptosis effects, we evaluated the apoptosis cells ( Figure 5D ) and caspase 3/7 activity ( Figure 5E) in the 4 groups. The number of apoptosis cells declined significantly in both the si-Lnc and miR-593 mimic groups (P < 0.05). The caspase 3/7 activity increased in the 2 groups but did not result in a significant difference within the two groups (P < 0.05).
| Reversed effects of PLK1 on ENST00000413528/miR-593/PLK1 signaling
Our previous data demonstrated that ENST00000413528 might act as a ceRNA to promote PLK1 expression by sponging miR-593;
we performed a restoration experiment for further verification.
Recombinant plasmid pcDNA3.1-PLK1 lacking 3'UTR, which was not able to bind to miR-593, was constructed and transfected into 
| D ISCUSS I ON
Recent evidence about lncRNAs has indicated that abnormal lncRNA expression may not only affect the regulation of eukaryotic genomes but also promote the growth of malignant cells, leading to tumor progression. 35, 36 Researchers usually use biological informational analysis, expression level regulation, dual luciferase reporter assay, RNA immunoprecipitation assay, and restore assay to conclude a ceRNA function. 37, 38 The current study provides evidence for overexpressed ENST00000413528's role as a tumorpromoting gene in glioma tissues and U251 and LN229 cell lines.
As shown in Figures 3A and 4A clinical use of PLK1 targeted therapy. In our study, we designed our research from another aspect. We found a new functional lncRNA ENST00000413528, which may regulate PLK1 expression via miR-593-5p. Different with PLK1 inhibitors, our research enriched the upstream regulatory network mechanism of PLK1, and may provide some fundamental evidence for further PLK1 pathway studies.
Taken together, our results reveal a regulatory axis of lncRNA ENST00000413528/miR-593/PLK1 in glioma, to our knowledge, this is the first research project of lncRNA ENST00000413528 expression profile in glioma. These findings could help us enrich the knowledge on the mechanism of glioma carcinogenesis and find new diagnostic or therapeutic targets related to lncRNA F I G U R E 6 Reversed effects of PLK1 on ENST00000413528/miR-593/PLK1 signaling. Cells were divided into seven groups: a blank group without any treatment; an si-Lnc group with an si-Lnc lentivirus fluid stable infection; an miR-593 group with miR-593 mimic transfection; an si-PLK1 group with si-PLK1 transfection; a pcDNA3.1-PLK1 group with pcDNA3.1-PLK1 (lacking 3′UTR) transfection; an si-Lnc + pcDNA3.1-PLK1 group with pcDNA3.1-PLK1 transfected into si-Lnc stably infected cells; and an miR-593 + pcDNA3.1-PLK1 group with miR-593 mimics and pcDNA3.1-PLK1 cotransfection. A, The relative expression levels of the PLK1 protein in the seven groups, with GAPDH serving as an internal reference. B, The number of cell colonies in the seven groups. C, The number of apoptosis cells detected by flow cytometry in the seven groups. D, Correlation analysis between the relative expression levels of PLK1 mRNA and ENST00000413528 in 16 pair of glioma and paired peritumoral brain edema (PTBE) tissues ENST00000413528, miR-593-5p, or PLK1 for glioma. However, the roles of lncRNAs in gliomas are diverse and the molecular pathway networks involved are also very complex, further studies are also necessary to elucidate to fully understand the mechanisms.
| CON CLUS ION
LncRNA ENST00000413528 is overexpressed in both human glioma tissues and U251 and LN229 cells; additionally, the knockdown of ENST00000413528 in glioma cells inhibits cell proliferation and colony formation abilities and induces the G0/G1 arrest of the cell cycle, and promotes apoptosis via a miR-593-5p/PLK1
pathway.
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